Ya Cao
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism 36
- Cancer-related molecular mechanisms research 21
- Oncology top 0.5%
- Viral-associated cancers and disorders 69
- Cancer-related Molecular Pathways 26
- Immunology top 1%
- interferon and immune responses 19
- Molecular Biology top 0.5%
- RNA modifications and cancer 49
- Epigenetics and DNA Methylation 25
- Hepatology top 1%
-
- Lymphoma Diagnosis and Treatment 24
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Oncotarget (9 papers)Journal of Experimental & Clinical Cancer Research (8 papers)Cancer Letters (6 papers)
- Partner nations
- ChinaUnited StatesSaudi Arabia
In The Last Decade
Ya Cao
304 papers receiving 12.5k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Cancer Research 4.7k
- Oncology 3.9k
- Immunology 2.2k
- Molecular Biology 7.2k
- Hepatology 564
Countries citing papers authored by Ya Cao
This map shows the geographic impact of Ya Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya Cao more than expected).
Fields of papers citing papers by Ya Cao
This network shows the impact of papers produced by Ya Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya Cao. The network helps show where Ya Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ya Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2021 | 14 | |
| 4 | 2021 | 15 | |
| 5 | Kounis Syndrome Induced by Anisodamine: A Case Report | 2020 | 1 |
| 6 | Preparation and SPECT/CT Imaging of 177Lu-Labeled Peptide Nucleic Acid (PNA) Targeting CITED1: Therapeutic Evaluation in Tumor-Bearing Nude Mice | 2020 | 1 |
| 7 | 2020 | 13 | |
| 8 | 2019 | 114 | |
| 9 | Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNAbreakdown → | 2019 | 429 |
| 10 | 2019 | 82 | |
| 11 | 2019 | 9 | |
| 12 | A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53breakdown → | 2018 | 402 |
| 13 | 2018 | 4 | |
| 14 | 2017 | 123 | |
| 15 | 2015 | 25 | |
| 16 | 2013 | 147 | |
| 17 | 2013 | 91 | |
| 18 | Latest advances in hypoxia inducible factor-1 signaling pathway | 2011 | 1 |
| 19 | 2004 | 3 | |
| 20 | Epstein-Barr virus LMP-1 activated AP-1 mediated by JNK in nasopharyngeal cell line | 2001 | 3 |
About Ya Cao
Ya Cao is a scholar working on Cancer Research, Oncology, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 311 papers that have together received 12.6k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (69 papers), RNA modifications and cancer (49 papers), Cancer, Hypoxia, and Metabolism (36 papers), Cancer-related Molecular Pathways (26 papers), Epigenetics and DNA Methylation (25 papers), Lymphoma Diagnosis and Treatment (24 papers), Cancer-related molecular mechanisms research (21 papers) and interferon and immune responses (19 papers). The work is most often cited by research in Cancer Research (4.7k citations), Oncology (3.9k citations), Immunology (2.2k citations), Molecular Biology (7.2k citations) and Hepatology (564 citations). Ya Cao has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Ann M. Bode, Jia Fan, Xiangjian Luo, Jian Zhou, Min Tang, Yongguang Tao, Lifang Yang, Zigang Dong, Xiaowu Huang and Zheqiong Tan. Their work appears in journals such as Oncotarget, Journal of Experimental & Clinical Cancer Research, Cancer Letters, BMC Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.